India pharma majors Dr Reddy’s, Wockhardt, and others deny allegations of conspiracy to fix prices in US – Firstpost

India pharma majors Dr Reddy’s, Wockhardt, and others deny allegations of conspiracy to fix prices in US – Firstpost ‘; $(“#aid_” + id + ” .dynamicArticle”).find(‘.content-wap-ros-new’).html(slot_html); createAd7(slot_id,adCount); slot_id = ”; slot_id = “infinite_content_8th_slot_no” + id; slot_html = ”; $(“#aid_” + id + ” .dynamicArticle”).find(‘.content-wap-ros’).html(slot_html); //createAd8(slot_id,adCount); slot_id = ”; slot_id = “infinite_content_ib_slot_no” + id; slot_html =…

View More India pharma majors Dr Reddy’s, Wockhardt, and others deny allegations of conspiracy to fix prices in US – Firstpost

Glenmark Pharma rises nearly 2% on USFDA approval – Moneycontrol.com

Shares of Glenmark Pharma rose nearly 2 percent intraday Friday after it received final approval from USFDA for Clindamycin and Benzoyl Peroxide Gel. According to company release on BSE, Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Clindamycin and Benzoyl Peroxide Gel, 1%|5%, a…

View More Glenmark Pharma rises nearly 2% on USFDA approval – Moneycontrol.com

Marksans Pharma slips 4% post USFDA inspection at Goa facility – Moneycontrol.com

Shares of Marksans Pharma slipped 4 percent intraday Thursday after USFDA issued Form 483 with eight observations. USFDA has concluded inspection at Goa facility which took place between February 25 and March 6, 2019, resulting in a Form 483 with eight observations. None of these observations are considered either critical or repetitive in nature. Company…

View More Marksans Pharma slips 4% post USFDA inspection at Goa facility – Moneycontrol.com

Lupin, Sun Pharma, Glenmark recall products in US – Moneycontrol.com

Indian drug majors Lupin, Sun Pharma and Glenmark Pharmaceuticals are recalling various drugs from the US market for a variety of reasons. As per the latest Enforcement Report published by the US Food and Drug Administration (USFDA), Lupin is voluntarily recalling 55,000 vials and 1,60,241 boxes of anti-bacterial drug Ceftriaxone for injection in various strengths.…

View More Lupin, Sun Pharma, Glenmark recall products in US – Moneycontrol.com

Sun Pharma jumps over 2% as its unit gets relief in US patent infringement case – Moneycontrol.com

Shares of Sun Pharmaceutical Industries rose over 2 percent intraday on December 27 after its unit DUSA Pharmaceuticals got injunctive relief in a US patent infringement case. The stock gained as much as 2.4 percent, quoting at Rs 424 on the BSE. A US district court prohibited Biofrontera and other defendants from using DUSA’s confidential and proprietary…

View More Sun Pharma jumps over 2% as its unit gets relief in US patent infringement case – Moneycontrol.com

Alembic Pharma raises Rs 350 crore via NCDs – Moneycontrol.com

Drug firm Alembic Pharmaceuticals on Friday said it has raised Rs 350 crore through allotment of non-convertible debentures (NCDs) on private placement basis. “The NCD committee of Alembic Pharmaceuticals Ltd…has allotted 1,500, 9 per cent rated unsecured listed redeemable non-convertible debentures (NCDs)… aggregating to Rs 150 crore under tranche I,” Alembic Pharmaceuticals said in a…

View More Alembic Pharma raises Rs 350 crore via NCDs – Moneycontrol.com

Sun Pharma to acquire Japan’s Pola Pharma for $1 million

Sun Pharma shares Monday ended 2.88% down at ₹510.65 on the BSE. New Delhi: Sun Pharma Monday said it will acquire Japan-based Pola Pharma for around $1 million to strengthen its presence in dermatology segment across the globe. The company has entered into a definitive agreement to acquire Pola Pharma, which is engaged in research…

View More Sun Pharma to acquire Japan’s Pola Pharma for $1 million

Online pharma sale can’t be regulated till Centre makes rules: TN regulator

In the latest development in the litigation against online pharmacy sales in the country, the State Food Safety and Drug Administration Department of Tamil Nadu has submitted before the court that the online sale of medicines cannot be regulated until rules governing it are framed. The counter affidavit was filed by the Director of Drugs…

View More Online pharma sale can’t be regulated till Centre makes rules: TN regulator

Sun pharma invests 120 crore in Assam to set up production line

GUWAHATI: Pharmaceutical Company, Sun Pharma has invested Rs 120 crore in Assam to set up production line which will boost the company’s capacity to manufacture liquid vials, injectable, eye drops and tablets. According to statement from Assam government the company has already invested Rs 700 crore in this manufacturing facility in the state and another…

View More Sun pharma invests 120 crore in Assam to set up production line

Sun Pharma expects normalisation of India business in Financial year 2019

By PTI NEW DELHI: Sun Pharma expects its India business to stabilise in the current fiscal leading to “reasonable volume growth” after witnessing disruptions in 2017-18 due to GST implementation, a top company official said. In a message to shareholders in the company’s Annual Report for 2017-18, Sun Pharma Managing Director Dilip Shanghvi however said…

View More Sun Pharma expects normalisation of India business in Financial year 2019